Cambia (Royalty Interest) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Cambia (Royalty Interest) General Information

Description

A pharmaceutical product indicated for the treatment of migraine. The drug provides migraine pain relief in 2 hours with effects starting within 15 minutes from consumption.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
SWK Holdings
Primary Office
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cambia (Royalty Interest) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cambia (Royalty Interest)‘s full profile, request access.

Request a free trial